ConductScience.org, home

Trial · NCT03237065

Results by group166

Each measurement the trial posted, group by group, in the words and numbers it posted.

OutcomeGroupCategoryValueSpreadUnits
Incidence of Hypophosphatemia (S-phosphate Level <2 mg/dL)Iron Isomaltoside/Ferric Derisomaltose5Participants
Incidence of Hypophosphatemia (S-phosphate Level <2 mg/dL)Ferric Carboxymaltose42Participants
Time With Hypophosphatemia ( S-phosphate Level <2.0 mg/dL)Iron Isomaltoside/Ferric Derisomaltose1195% Confidence Interval 6 to 28days
Time With Hypophosphatemia ( S-phosphate Level <2.0 mg/dL)Ferric Carboxymaltose2895% Confidence Interval 15 to 61days
Proportion of Subjects With Hypophosphatemia on Day 35 (S-phosphate Level <2.0 mg/dL)Iron Isomaltoside/Ferric Derisomaltose0Participants
Proportion of Subjects With Hypophosphatemia on Day 35 (S-phosphate Level <2.0 mg/dL)Ferric Carboxymaltose25Participants
Absolute [∆] Changes in S-phosphate From Baseline to Day 1, 7, 8, 14, 21, and 35Iron Isomaltoside/Ferric DerisomaltoseDay 10.19Standard Deviation 0.57mg/dL
Absolute [∆] Changes in S-phosphate From Baseline to Day 1, 7, 8, 14, 21, and 35Ferric CarboxymaltoseDay 1-0.18Standard Deviation 0.50mg/dL
Absolute [∆] Changes in S-phosphate From Baseline to Day 1, 7, 8, 14, 21, and 35Iron Isomaltoside/Ferric DerisomaltoseDay 7-0.44Standard Deviation 0.57mg/dL
Absolute [∆] Changes in S-phosphate From Baseline to Day 1, 7, 8, 14, 21, and 35Ferric CarboxymaltoseDay 7-0.89Standard Deviation 0.74mg/dL
Absolute [∆] Changes in S-phosphate From Baseline to Day 1, 7, 8, 14, 21, and 35Iron Isomaltoside/Ferric DerisomaltoseDay 8-0.46Standard Deviation 0.64mg/dL
Absolute [∆] Changes in S-phosphate From Baseline to Day 1, 7, 8, 14, 21, and 35Ferric CarboxymaltoseDay 8-1.14Standard Deviation 0.74mg/dL
Absolute [∆] Changes in S-phosphate From Baseline to Day 1, 7, 8, 14, 21, and 35Iron Isomaltoside/Ferric DerisomaltoseDay 14-0.32Standard Deviation 0.60mg/dL
Absolute [∆] Changes in S-phosphate From Baseline to Day 1, 7, 8, 14, 21, and 35Ferric CarboxymaltoseDay 14-1.47Standard Deviation 0.80mg/dL
Absolute [∆] Changes in S-phosphate From Baseline to Day 1, 7, 8, 14, 21, and 35Iron Isomaltoside/Ferric DerisomaltoseDay 21-0.09Standard Deviation 0.66mg/dL
Absolute [∆] Changes in S-phosphate From Baseline to Day 1, 7, 8, 14, 21, and 35Ferric CarboxymaltoseDay 21-1.27Standard Deviation 0.88mg/dL
Absolute [∆] Changes in S-phosphate From Baseline to Day 1, 7, 8, 14, 21, and 35Iron Isomaltoside/Ferric DerisomaltoseDay 350.11Standard Deviation 0.49mg/dL
Absolute [∆] Changes in S-phosphate From Baseline to Day 1, 7, 8, 14, 21, and 35Ferric CarboxymaltoseDay 35-0.99Standard Deviation 0.96mg/dL
Relative [%] Changes in S-phosphate From Baseline to Day 1, 7, 8, 14, 21, and 35Iron Isomaltoside/Ferric DerisomaltoseDay 16.89Standard Deviation 16.02Percentage change from baseline
Relative [%] Changes in S-phosphate From Baseline to Day 1, 7, 8, 14, 21, and 35Ferric CarboxymaltoseDay 1-4.34Standard Deviation 15.28Percentage change from baseline

Source ClinicalTrials.govtrials-2026-11-12-0.5.0

Sources 3

  • ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
  • ClinicalTrials.govNo license stated
  • NIH RePORTER's clinical studies and project filesPublic domain
Each source's terms
  • ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
  • ClinicalTrials.govnone stated
  • NIH RePORTER's clinical studies and project filesPublic domain (NIH RePORTER)

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this list from software.

Twenty rows a page, as JSON. No key.

GET https://conductscience.org/api/trials/v1/NCT03237065/results